Sunday October 18

IMPORTANT: Documenting CE credit with ABB/PEER for the ASRM 2020 Virtual Scientific Congress & Expo:

If you attend a live session (abstract, poster, roundtable, or expert encounter), your activity will be tracked by the length of time you are logged into the activity. ASRM will forward this information directly to ABB/PEER within 45 days of your attendance.

If you attend an on-demand session that requires an evaluation (interactive, symposium, plenary, lecture, or post-graduate course), you must complete the evaluation by December 31, 2020, to obtain CE credit. ASRM will then forward this information directly to ABB/PEER within 45 days of your submission of the evaluation to ASRM.

The final date to claim credit with ASRM is December 31, 2020. Additional instructions for documenting your ASRM CE credit will be available soon.

Lecture (Up to .5 Contact Hour Each)

• PLE03 - 9:00 A.M. – Camran Nezhat, M.D. Lectureship in Innovations in Medicine: Innovations in Genetic Analysis of Embryos
• PLE04 - 1:10 P.M. – Plenary Lecture: Health Equity in Medicine

Oral Abstract Sessions (Up to .25 Contact Hour Each)

Patient Education and Support

• O-63 - 10:10 A.M. – Reading Level Of Patient Education Material On Infertility Clinic Websites Is Above National Recommendations
• O-66 - 10:55 A.M. – Optimizing Provider And Patient Experience: An Analysis Of An Online Tool For Preimplantation Genetic Testing (Pgt) Pre-Test Education

Male Factor

• O-67 - 9:40 A.M. – Increased Risk For Congenital Malformations In Relatives Of Men With Poor Semen Quality: Evidence From The Utah Population Database (UPDB)
• O-68 - 9:55 A.M. – Male Infertility Testing And Diagnoses Remain Infrequent For Infertile Couples
• O-69 - 10:10 A.M. – ICSI Outcomes Using Spermatozoa With Optimal Genomic Integrity
• O-70 - 10:25 A.M. – Male Factor Infertility And Placental Pathology In Live Births Conceived With In Vitro Fertilization
• O-71 - 10:40 A.M. – Relationship Between Semen Parameters And Paternal Origin Of Aneuploidy

Preimplantation Genetic Testing

• O-73 - 9:40 A.M. – A Multi-Center, Prospective, Blinded, Non-Selection Study Evaluating The Predictive Value (PV) Of An Aneuploid Diagnosis With PGT-A And The Impact Of Biopsy
• O-74 - 9:55 A.M. – Identity Marker Analysis Demonstrates That Most Initial And Re-Biopsy Pairs Are Concordant
• O-75 - 10:10 A.M. – Do We Still Need To Deprioritize The Transfer Of ‘Low Grade Mosaic Embryos’?
• O-76 - 10:25 A.M. – IVF PGT-M Versus Natural Conception With Prenatal Diagnosis For Huntington’s Disease: A Cost-Effectiveness Analysis
• O-77 - 10:40 A.M. – Transfer Outcomes Of Embryos With Preimplantation Genetic Testing For Aneuploidy (PGT-A) Diagnoses Of Undetermined Reproductive Potential: Results From A Prospective, Blinded, Multi-Center Non-Selection Study
• O-78 - 10:55 A.M. – Segmental Aneuploidy Rates Observed In ~192,000 Blastocysts By Fast-Seqs Support Inclusion In PGT-A Assays

Reproductive Biology: Human Studies

• O-79 - 9:40 A.M. – Insulin-Like Growth Factor 2 Promotes Development And Function Of Macaque Preantral Follicles During Three-Dimensional Culture
• O-80 - 9:55 A.M. – Loss Of Expression Of The Noncoding Rna H19 Promotes Susceptibility To Gonadotoxin-Induced Ovarian Dna Damage
• O-81 - 10:10 A.M. – Non-Invasive Metabolic Imaging Of Cumulus Cells To Detect Oocyte Maturity And Fertilization
• O-82 - 10:25 A.M. – Endometrial Mitochondrial Dna Secreted In Extracellular Vesicles: A Novel Maternal Mechanism Modulating Embryo Bioenergetics
• O-83 - 10:40 A.M. – Altered Blastocyst Methylome And Imprinting Dysregulation Associated With The Prolonged Disease State Of Infertility
• O-84 - 10:55 A.M. – Gene Conversion In Human Embryos Induced By Gene Editing

Reproductive Surgery and Procedures

• O-87 - 10:10 A.M. – Quantifying Heterogeneity Of Testicular Histopathology In Non-Obstructive Azoospermic Men
• O-88 - 10:25 A.M. – Evaluating The Quality Of Reporting In Outcomes Of Microsurgical-Tese In Men With Non-Obstructive Azoospermia (NOA): A Methodological Analysis
• O-89 - 10:40 A.M. – Effects Of Preoperative Medical Treatment On Sperm Retrieval Rates In Primary And In Recurrent Micro Tese Cases

Cryopreservation and Frozen Embryo Transfer

• O-91 - 1:50 P.M. – Successful Production Of Normal Euploid Human Blastocysts Derived From Sperm After Partial Freeze Drying, Rehydration And ICSI: Towards Developing A Novel Method For Safe Storage Of Biological Samples
• O-92 - 2:05 P.M. – Embryo Vitrification In Super Cooled Slush Nitrogen Results In Superior Post-Thaw Survival Compared To Conventional Liquid Nitrogen: A Blinded, Randomized Controlled Trial
• O-93 - 2:20 P.M. – Upright, Upside Down, Sideways - Effects Of Orientation Of Vapor Shippers And Data Loggers On Hold Time
• O-94 - 2:35 P.M. – A Novel Organ Culture System Supported Germ Cell Survival In Primates And Spermatogenesis In Mice
• O-96 - 3:05 P.M. – Does Trophectoderm Biopsy Affect Blastocyst’s Expansion Rate Post Thawing?

Androgen Excess

• O-97 - 1:50 P.M. – Working Hard Or Hardly Working: Does PCOS Impact The Mitochondrial Dna Content Of The Embryo
• O-101 - 2:50 P.M. – An Amh-Based Screening Tool Is Both Sensitive And Specific For Predicting A Diagnosis Of PCOS By Rotterdam Criteria
• O-102 - 3:05 P.M. – Polycystic Ovary Syndrome Is Associated With Increased Aneuploidy Rate

ART Lab: Outcome Predictors

• O-103 - 1:50 P.M. – Clinical Implementation Of Algorithm-Based Embryo Selection Using Multi-Dimensional Analysis Of ‘Big Data’ Improves Pregnancy Outcomes In Single Thawed Euploid Embryo Transfers (Euploid Sets)
• O-104 - 2:05 P.M. – Euploidy Rates And Pregnancy Outcomes Using The Zymōt™ Device For Sperm Preparation
• O-105 - 2:20 P.M. – Accurate Measurement Of Sperm Dna Fragmentation Effect On Reproductive Outcomes By Cumulative Livebirth Rates (Clbr) Per Embryo Transferred And Oocyte Utilized Reveals Its Lack Of Relevance In Oocyte Donation For Unselected Males
• O-106 - 2:35 P.M. – Presence Of Abnormal Cell Cleavage, Cell Fusion Or Both Seen During Embryo Development On Time-Lapse Microscopy Is Not Predictive Of Chromosomal Aneuploidy
• O-107 - 2:50 P.M. – Does Tobacco Affect Follicular And Embryo Health?
• O-108 - 3:05 P.M. – Ultra Low Oxygen Exposure During Extended Culture Of Human In Vitro Embryo Significantly Improves Usable Blastulation And Cumulative Live Birth Rates In In Vitro Fertilization

Early Pregnancy

• O-112 - 2:35 P.M. – Parental Origin Of Embryonic Aneuploidy In Couples With Recurrent Pregnancy Loss
• O-113 - 2:50 P.M. – Single Nucleotide Polymorphism (SNP) Array Analysis Of 63,277 Products Of Conception (POC) Samples: A 10-Year Laboratory Experience

Legal and Ethical Reproductive Issues

• O-118 - 2:35 P.M. – Elective Single Embryo Transfer Rates In The Era Of Preimplantation Genetic Testing And Gestational Carriers: A SART Review
• O-119 - 2:50 P.M. – Liability For Embryo Mix-Ups: Legal Case Review And Recommendations

Video Abstracts (.1 Contact Hour)

• V-09 - 10:06 A.M. – A New Piezo Drill For Human ICSI

Roundtable Discussions (Up to .75 Contact Hour Each)

• RD2-03 - 11:15 A.M. – PGT for Late Onset Disorders
• RD2-04 - 11:15 A.M. – Cost Effectiveness of PGT-A
• RD2-05 - 11:15 A.M. – Status of Comprehensive PGT
• RD2-06 - 11:15 A.M. – Generating Embryos from Stem Cells and Artificial Structures
• RD2-07 - 11:15 A.M. – Blood-Testis-Barrier and the Effect of Testicular Sperm Aspiration and Biopsy on Testicular Microenvironment
• RD2-08 - 11:15 A.M. – What Can We Learn from SART CORS and the New Clinic Summary Report/National Summary Report?
• RD2-09 - 11:15 A.M. – Embryo Storage Options: Onsite Vs Offsite?
• RD2-10 - 11:15 A.M. – Egg Freezing Success Rates: Perceptions Vs Reality
• RD2-16 - 11:15 A.M. – Management of a Hormone Laboratory as Part of an IVF Laboratory
• RD2-17 - 11:15 A.M. – Use of Artificial Intelligence in the ART Laboratory
• RD2-18 - 11:15 A.M. – PGT Technologies: How to Know What Is Safe and Effective For Your Patients

Symposia (Up to .75 Contact Hour Each)

• SY2-01 - 12:10 P.M. – Howard and Georgeanna Jones Endowed Symposium on Assisted Reproductive Technology: Mechanisms of Ovarian Follicle Development: Scientific Basis of Performing Sound Ovarian Stimulation
• SY2-02 - 12:10 P.M. – Middle East Fertility Society (MEFS) Symposium: Management of Mosaic Embryos After PGT-A
• SY2-05 - 12:10 P.M. – Examining Genetic Risk for Gamete Donors: Current Approaches to Family History and Carrier Screening
• SY2-06 - 12:10 P.M. – US Food & Drug Administration (FDA) Symposium: Reproductive HCT/P Donor Eligibility and Compliance Update for Reproductive HCT/P Establishments

Interactive Sessions (Up to .75 Contact Hour Each)

• IN2-01 - 3:30 P.M. – Antioxidants and Male Fertility: Should Men Take Supplements or Not?
• IN2-03 - 3:30 P.M. – Embryos v. Eggs? Emerging Fertility Preservation Challenges
• IN2-05 - 3:30 P.M. – Reproductive Immunology and ART: A Second Look
• IN2-06 - 3:30 P.M. – SART Reporting: “How to” Guide?

Click a day below for details regarding ABB/PEER-approved scientific sessions, roundtables, abstracts, and post-graduate courses.